Stroke
Conditions
Brief summary
Spasticity and pain, particularly int he shoulder region, are the most common impairments experienced by subjects who had experienced a stroke. There is preliminary evidence supporting the role of dry needling for spasticity in patients who had suffered from a stroke. Few data exists on the effects on shoulder pain. In addition, it has been shown that application of dry needling induces post-needling soreness in individuals with musculoskeletal pain. No previous study has investigated the presence and the duration of post-needling soreness in individuals who had experienced a stroke.
Interventions
OTHERDry Needling
A single session of modulatory interventions combined with a single session of dry needling into the shoulder muscles which active trigger points will reproduce the shoulder pain symptoms.
OTHERPhysical Therapy
A single session of modulatory interventions targeting modulation of central nervous system.
Sponsors
Universidad Rey Juan Carlos
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* first-ever unilateral stroke; * hemiplegia resulting from stroke; * age between 30 and 60 years old; * presence of hypertonicity in the upper extremity; * pain symptoms in the shoulder * active trigger points in the shoulder muscles reproducing the shoulder pain symptoms
Exclusion criteria
* recurrent stroke; * absence of active trigger points in the shoulder muscles reproducing shoulder symptoms * previous treatment with nerve blocks, motor point injections with neurolytic agents for spasticity at any time; * previous treatment with botulinum toxin-A in the 6 months prior the study; * severe cognitive deficits; * other neurologic diseases, * underlying complex medical conditions, e.g., heart conditions, unstable hypertension, fracture * fear to needles; * any contraindication for deep dry needling, e.g., anticoagulants, infections, bleeding, or psychotic.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in post-dry needling pain intensity with a numerical pain rate scale before and after the intervention | Baseline, 24 hours (1 day) after and 72 hours (3 days) after treatment the intervention | A Numerical Pain Rate Scale (NPRS, 0-10) will be used to record post-dry needling soreness in the targeted area |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in spontaneous shoulder pain with a numerical pain rate scale before and after the intervention | Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention | A Numerical Pain Rate Scale (NPRS, 0-10) will be used to assess spontaneous shoulder pain |
| Presence of active trigger points in the shoulder musculature | Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention | Manual palpation of active trigger points in the shoulder muscles will be conducted |
Countries
Spain
Outcome results
None listed